Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Susceptibility to mycobacterial infection in VEXAS syndrome.
Riescher S, Lecomte R, Danic G, Graveleau J, Le Bris Y, Hello M, Guillouzouic A, Guardiolle V, Garnier A, Grossi O, Gaborit B, Néel A. Riescher S, et al. Among authors: garnier a. Rheumatology (Oxford). 2024 Feb 5:keae087. doi: 10.1093/rheumatology/keae087. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38317027
Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier.
Garnier A, Guillaume T, Peterlin P, Béné MC, Le Bris Y, Dubruille V, Mahé B, Gastinne T, Touzeau C, Blin N, Le Gouill S, Moreau P, Chevallier P. Garnier A, et al. Bone Marrow Transplant. 2017 Jul;52(7):1063-1064. doi: 10.1038/bmt.2017.60. Epub 2017 Apr 3. Bone Marrow Transplant. 2017. PMID: 28368382 No abstract available.
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
Lestang E, Peterlin P, Le Bris Y, Dubruille V, Delaunay J, Godon C, Theisen O, Blin N, Mahe B, Gastinne T, Garnier A, Touzeau C, Voldoire M, Bene MC, Le Gouill S, Milpied N, Mohty M, Moreau P, Guillaume T, Chevallier P. Lestang E, et al. Among authors: garnier a. Eur J Haematol. 2017 Jul;99(1):60-69. doi: 10.1111/ejh.12891. Epub 2017 May 5. Eur J Haematol. 2017. PMID: 28370306
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies.
Chevallier P, Peterlin P, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Le Bris Y, Béné MC, Le Gouill S, Moreau P, Guillaume T. Chevallier P, et al. Among authors: garnier a. Oncotarget. 2018 Sep 11;9(71):33528-33535. doi: 10.18632/oncotarget.26083. eCollection 2018 Sep 11. Oncotarget. 2018. PMID: 30323896 Free PMC article.
Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies.
Le Bris Y, Costes D, Bourgade R, Guillaume T, Peterlin P, Garnier A, Le Bourgeois A, Chevallier P, Béné MC. Le Bris Y, et al. Among authors: garnier a. Bone Marrow Transplant. 2022 Sep;57(9):1435-1441. doi: 10.1038/s41409-022-01747-x. Epub 2022 Jun 28. Bone Marrow Transplant. 2022. PMID: 35764681
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.
De Almeida Braga C, Bauvais M, Sujobert P, Heiblig M, Jullien M, Le Calvez B, Richard C, Le Roc'h V, Rault E, Hérault O, Peterlin P, Garnier A, Chevallier P, Bouzy S, Le Bris Y, Néel A, Graveleau J, Kosmider O, Paul-Gilloteaux P, Normand N, Eveillard M. De Almeida Braga C, et al. Among authors: garnier a. Int J Lab Hematol. 2025 Feb;47(1):120-129. doi: 10.1111/ijlh.14368. Epub 2024 Sep 14. Int J Lab Hematol. 2025. PMID: 39275905
Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults.
Le Bris Y, Guillaume T, Ménard A, Illiaquer M, Martin J, Malard S, Duquesne A, Peterlin P, Debord C, Robillard N, Eveillard M, Wuillème S, Delaunay J, Mohty M, Garnier A, Moreau P, Béné MC, Chevallier P. Le Bris Y, et al. Among authors: garnier a. Bone Marrow Transplant. 2017 Jun;52(6):854-858. doi: 10.1038/bmt.2016.364. Epub 2017 Jan 30. Bone Marrow Transplant. 2017. PMID: 28134920 Clinical Trial.
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide.
Garnier A, Delbos F, Guillaume T, Peterlin P, Le Bourgeois A, Béné MC, Le Bris Y, Malard S, Duquesne A, Gauvrit I, Moreau P, Cesbron A, Chevallier P. Garnier A, et al. Bone Marrow Transplant. 2018 Aug;53(8):1044-1047. doi: 10.1038/s41409-018-0107-7. Epub 2018 Feb 1. Bone Marrow Transplant. 2018. PMID: 29391525 No abstract available.
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.
Boutault R, Peterlin P, Boubaya M, Sockel K, Chevallier P, Garnier A, Guillaume T, Le Bourgeois A, Debord C, Godon C, Le Bris Y, Theisen O, Kroschinsky F, Moreau P, Béné MC, Platzbecker U, Eveillard M. Boutault R, et al. Among authors: garnier a. Br J Haematol. 2018 Dec;183(5):736-746. doi: 10.1111/bjh.15626. Epub 2018 Nov 8. Br J Haematol. 2018. PMID: 30406952 Free article.
454 results